Hematopoietic stem cell transplantation and chimeric antigen receptor T cell for relapsed or refractory diffuse large B-cell lymphoma

AIM: Autologous hematopoietic stem cell transplantation (ASCT) is the standard-of-care curative treatment for relapsed or refractory diffuse large B-cell lymphoma (RR-DLBCL), but the relapse rate is usually high. MATERIALS & METHODS: In this study, we treated 14 RR-DLBCL patients by combining AS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immunotherapy
Main Authors: Wang, Tao, Gao, Lei, Wang, Yujie, Zhu, Wenjun, Xu, Lili, Wang, Yang, Yue, Wenqin, Tang, Gusheng, Chen, Li, Chen, Jie, Zhang, Weiping, Yu, Xuejun, Feng, Dongge, Yang, Jianmin
Formato: Artigo
Idioma:Inglês
Publicado em: Future Medicine Ltd 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7546158/
https://ncbi.nlm.nih.gov/pubmed/32752910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados